IGC Pharma
0.3991
-0.0188
-4.50%
IGC
10-10 16:10:00(美东时间)
高
0.4250
开
0.4170
量
67.29万股
总市值
3670.09万
低
0.3925
换
0.73%
额
27.31万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
IGC Pharma(IGC)
10-02 04:45
$IGC Pharma(IGC)$
8-K Current report, items 1.01 and 9.01 Accession Number: 0001185185-25-001326 Act: 34 Size: 250 KB
网页链接
IGC Pharma(IGC)
09-20 04:05
$IGC Pharma(IGC)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001185185-25-001235 Act: 33 Size: 306 KB
网页链接
IGC Pharma(IGC)
08-19 18:05
$IGC Pharma(IGC)$
DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001185185-25-001023 Act: 34 Size: 131 KB
网页链接
IGC Pharma(IGC)
08-19 03:05
$IGC Pharma(IGC)$
DEF 14A Other definitive proxy statements Accession Number: 0001185185-25-001021 Act: 34 Size: 1 MB
网页链接
IGC Pharma(IGC)
08-15 04:15
$IGC Pharma(IGC)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001185185-25-000997 Act: 34 Size: 9 MB
网页链接
IGC Pharma(IGC)
08-04 18:15
$IGC Pharma(IGC)$
PRE 14A Other preliminary proxy statements Accession Number: 0001185185-25-000890 Act: 34 Size: 1 MB
网页链接
IGC Pharma(IGC)
07-29 18:15
$IGC Pharma(IGC)$
EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002377 Act: 33 Size: 1 KB
网页链接
IGC Pharma(IGC)
07-19 05:25
$IGC Pharma(IGC)$
S-3 Registration statement under Securities Act of 1933 Accession Number: 0001185185-25-000808 Act: 33 Size: 197 KB
网页链接
IGC Pharma(IGC)
06-28 04:25
$IGC Pharma(IGC)$
10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001185185-25-000706 Act: 34 Size: 8 MB
网页链接
IGC Pharma(IGC)
06-17 20:45
$IGC Pharma(IGC)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001185185-25-000657 Act: 34 Size: 133 MB
网页链接
IGC Pharma(IGC)
05-16 04:15
$IGC Pharma(IGC)$
5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-000493 Size: 11 KB
网页链接
IGC Pharma(IGC)
05-16 04:15
$IGC Pharma(IGC)$
5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-000494 Size: 14 KB
网页链接
IGC Pharma(IGC)
05-16 04:15
$IGC Pharma(IGC)$
5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-000495 Size: 11 KB
网页链接
IGC Pharma(IGC)
05-16 04:15
$IGC Pharma(IGC)$
5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-000496 Size: 14 KB
网页链接
IGC Pharma(IGC)
02-15 05:05
$IGC Pharma(IGC)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001185185-25-000137 Act: 34 Size: 4 MB
网页链接
IGC Pharma(IGC)
2024-11-13 05:15
$IGC Pharma(IGC)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001185185-24-001096 Act: 34 Size: 6 MB
网页链接
IGC Pharma(IGC)
2024-09-28 04:15
$IGC Pharma(IGC)$
8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001185185-24-000923 Act: 34 Size: 280 KB
网页链接
IGC Pharma(IGC)
2024-09-28 04:15
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-24-000924 Size: 5 KB
网页链接
IGC Pharma(IGC)
2024-08-27 18:15
$IGC Pharma(IGC)$
8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001185185-24-000851 Act: 34 Size: 199 KB
网页链接
IGC Pharma(IGC)
2024-08-15 04:25
$IGC Pharma(IGC)$
SC 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001185185-24-000811 Act: 34 Size: 44 KB
网页链接